Description
Contains active ingredients including Miconazole. Glenmark.Composition:Covarex contains:Miconazole nitrate - 2g per 100g.Preservatives:Imidurea - 0.2% m/m.Methyl paraben - 0.15% m/m.Sodium propylparaben - 0.15% m/m.Anti-oxidant:Butyl hydroxytoluene - 0.02% m/m.Pharmacological classification: A 13.9.2 fungicides.Pharmacological action:Miconazole nitrate is a fungistatic. In candida albicans it inhibits transformation of blastospores into invasive mycelial form.Indications:Covarex is indicated in the topical treatment of cutaneous candidiasis caused by candida albicans and of tinea corporis (ringworm of the body), tinea cruris (ringworm of the groin) and tinea pedis (ringworm of the foot) caused by trichophyton rubrum, T. mentagrophytes, and epidermophyton floccosum.Contra-indications:Hypersensitivity to miconazole nitrate or any other ingredients of Covarex.Identification:A smooth white to greyish white cream.Presentation:Polyethylene laminated aluminium tubes of 30g, 40g and 50g with white screw cap.Marketed by Glenmark Pharmaceuticals South Africa (Pty) Ltd.Date of publication of this package insert:24 August 2007.Use in a topical treatment of cutaneous candidiasis caused by candida albicans and of tinea corporis (ringworm of the body).Tinea cruris (ringworm of the groin) and tinea pedis (athlete's foot).
Pack size: 30g
Dosage and directions for use: Apply Covarex twice daily (morning and evening) for cutaneous candidiasis and tinea corporis, tinea cruris and tinea pedis.To reduce the possibility of recurrence, apply Covarex for 2 weeks in the treatment of candida infections, tinea cruris and tinea corporis and apply Covarex for one month in the treatment of tinea pedis.Avoid occlusive dressings when this medication is used in the treatment of candidiasis as it provides conditions that favour growth of yeast and release of its irritating endotoxin.
Storage instructions: Storage instructions:Store below 25 degrees C and do not freeze.
Warnings:
For external use only.Continue to apply Covarex for the full period of treatment as indicated under the heading "dosage and directions for use".Side-effects and special precautions:Covarex may cause blistering, burning, redness, skin rash or other sign of skin irritation and contact dermatitis not present before therapy.After prolonged and extensive application, systemic absorption can not be excluded that may result in side-effects usually associated with systemically administered miconazole nitrate such as anaemia, hepatotoxicity, thrombocytopenia, dizziness, drowsiness, headache, flushing or redness of face or skin and gastrointestinal disturbances.Safety of topical use during pregnancy and lactation has not been established.Known symptoms of overdosage and particulars of its treatment:No known symptoms. See "side effects and special precautions". Treatment is symptomatic and supportive.For external use only.Keep out of the reach of children.
Ingredients: Miconazole Nit 2% Cream